It also shows that restoring the integrity of the epigenome reverses age-related symptoms.
Learn more at https://hms.harvard.edu/news/loss-epi…
Tag Archives: Medical Reviews
Review: Abbott’s Discrete New Glucose Monitor
Abbott Laboratories newest continuous glucose monitor is now available at participating retail pharmacies and through durable medical equipment suppliers. The Freestyle Libre 3 was approved by the FDA in June and is a step up from previous Abbott systems.
Abbott Laboratories and Dexcom are the leaders in the CGM market, which hit $5.1 billion in revenue in 2021 and is expected to reach $13.2 billion by 2028, according to Vantage Market Research. Abbott’s CGM systems, called FreeStyle Libre, generated $3.7 billion in revenue last year, with 4 million users globally.
CNBC’s Erin Black, a type 1 diabetic, tested out the Libre 3 for over a month. Here is her review.
Covid-19: A Review Of The Best Rapid At-Home Tests
New high-tech Covid-19 tests promise better and earlier detection of the virus—similar to a PCR test. WSJ’s Joanna Stern (and her mannequin clone) tried out the Detect Covid-19 Test and Cue Health Monitoring System to see how they compare with rapid antigen tests. Photo illustration: Ryan Trefes/ WSJ
Medicine: Transcatheter Treatments For Valvular Heart Disease (JAMA Video)
Transcatheter valvular repair and implantation has become increasingly common for treating patients diagnosed with valvular heart diseases.
0:00 This video summarizes the three transcatheter valvular therapies currently in use in the United States: transcatheter aortic valve implantation (TAVI), transcatheter valve-in-valve procedures, and transcatheter edge-to-edge mitral valve repair.
0:47 Transcatheter aortic valve replacement (TAVI) for patients with severe aortic stenosis regardless of surgical risk 2:47 Transcatheter valve-in-valve procedures for patients with bioprosthetic valve failure
3:35 Transcatheter mitral valve repair for high surgical risk degenerative mitral regurgitation and for severe functional mitral regurgitation regardless of surgical risk.
An obscure think tank in Boston is getting drug companies to lower their prices – using something called a QALY. WSJ’s Denise Roland explains what a QALY is, and why it’s controversial.
Boomers Daily 